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Abstract 
In the field of label-free biosensing, various transducer materials and strategies are 
under investigation to overcome the Debye-screening limitation of biomolecule charges, 
which is a main limiting factor to detect clinically relevant biomarkers in physiological 
matrices. We demonstrate an in-line, impedimetric aptasensor with reduced graphene-
oxide (rGO) thin films as transducers to detect prostate specific antigens (PSA). Unlike 
classical electrochemical impedance spectroscopy (EIS), this direct, label-free and fully-
electronic biosensor approach does not need any redox markers. PSA dose-response 
experiments were done in phosphate buffer solution with physiological concentration 
with a theoretical Debye screening length of 0.76 nm. As specific capture molecules, 
short anti-PSA aptamers ensured a close binding of the target molecules to the 
transducer surfaces. Results showed a limit of detection smaller than 33 pM of PSA and 
a pronounced detection scale from 33 pM to 330 nM fully covering the clinically relevant 
range of PSA (115 - 290 pM). This promising performance is attributed to the bipolar 
electronic transport behavior of our ultra-thin rGO layers similar to pristine graphene. 
The attachment of target biomolecules to the films changes the surface potential 
resulting in a resistance change inside the rGO thin films. Such an in-line EIS with rGO 
thin films opens promising prospects for biosensing beyond the Debye-screening 
limitation, which is a major challenge for conventional semiconductor field-effect devices 
towards clinical applications.  
Index Terms 
reduced graphene-oxide thin-films, in-line electrochemical impedance spectroscopy, 
aptasensor, Debye-screening limitation  
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1. Introduction 
Electrochemical impedance spectroscopy (EIS) (Orazem and Tribollet, 2011),(Lisdat 
and Schafer, 2008),(Barsoukov and Macdonald, 2005),(Macdonald, 2005),(Macdonald, 
1990) is widely used as a promising sensitive, selective and label-free biosensing 
principle in solutions to analyze biorecognition events on their sensor surfaces. The 
technique extracts the complex impedance of a system under test by applying an 
alternating voltage perturbation of small amplitude (generally mV) in a certain frequency 
range and measuring the current response. Conventional EIS can be classified into 
faradaic and non-faradaic modes. Faradaic EIS measurements are usually done in the 
presence of redox molecules in the test solution and the amount in redox current varies 
by the electronic property of the working electrode. When biomolecules are binding to 
these electrodes, their accessible surface gets smaller and hence the redox current is 
reduced. Current decrease can then be related to the receptor-analyte binding at the 
surface and concentrations of analyte molecules can be measured. The total faradaic 
current also strongly relies on the electronic properties of the biomolecules, since some 
of the biomolecules can be redox-active, but most of the biomolecules act as insulating 
layer.  
For the non-faradaic EIS, the impedance measurement is carried out in absence of 
redox molecules to reveal the biorecognition event (Bart et al., 2005). A classical device 
configuration are interdigitated electrodes (IDEs), which are described as capacitive 
biosensors (Berdat et al., 2008),(Berdat et al., 2006),(Yang et al., 2004). They are 
known to exhibit a high sensitivity due to the confinement of the local electrical field 
closely inside the micrometer-size IDEs structures. In both faradaic and non-faradaic 
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EIS, conventional impedance measurements are detecting impedance changes of the 
biosystem between counter and working electrode by passing current through the buffer 
solution on top of them. Advanced transducer layers can be additionally applied in 
between the IDE finger electrodes and the biorecognition layer to amplify the output 
signals and to enhance the sensitivity of the sensors. In many cases, this improvement 
stems from improved immobilization density of the bio-recognition molecules on the EIS 
biosensor surface. 
In recent years in the field of biosensor and bioelectronics, chemically exfoliated 
graphene oxide (GO) and reduced graphene oxide (rGO) attracted plenty of attention 
due to its similarity to pristine graphene. Graphene (Novoselov et al., 2004),(Castro 
Neto et al., 2009),(Geim and Novoselov, 2007),(Novoselov et al., 2012),(Kahng et al., 
2012),(De and Coleman, 2010),(Baringhaus et al., 2014),(Huang et al., 2011) is an 
atomic 2D material and consists of a carbon hexagonal lattice that possesses high 
carrier mobility, excellent mechanical properties, high thermal stability and good 
biocompatibility. GO (Dreyer et al., 2010),(Eda and Chhowalla, 2010) and rGO (Bagri et 
al., 2010),(Gómez-Navarro, 2007),(Pei and Cheng, 2012) thin-films not only preserve 
this carbon lattice alike graphene to maintain the above-mentioned, promising 
properties within nanoscale, but also own various functional oxygen groups on their 
carbon basal plane. This is beneficial for chemical attachment of capture molecules to 
the thin films. Therefore, these two materials are intensively exploited as alternatives to 
overcome the dilemma that graphene is facing towards its wafer-scale fabrication and 
process integration (Suk et al., 2011),(Liang et al., 2011) such as robust, cost-effective 
biosensor device preparation, further-advanced surface functionalization and chemical 
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functionalization with receptor biomolecules. In most of the cases, rGO thin-films 
(Bonanni et al., 2012b),(Bonanni et al., 2012a) are utilized as transducer layers in 
conventional, faradaic EIS to enhance the sensing area by various functional oxygen 
groups on its carbon basal plane.  
In the present study, an in-line EIS biosensor platform was developed with rGO thin-
films as transducer layers on top of IDEs (Zaretsky et al., 1988),(Igreja and Dias, 2004), 
while the impedance was measured along the rGO thin-film. This biosensor transducer 
principle is working in a label-free mode without the use of any redox markers. Since in 
this configuration the IDE electrodes are bridged by a conductive material, already at 
low frequencies (1 Hz) significant changes in the impedance values upon biomolecule 
binding are visible. The promising semi-metal properties of rGO with a strong reaction to 
surface potential changes at the solid-liquid interface were advantageous for 
biosensing. In addition a short, 32 base pair anti-PSA aptamer sequence as ultra-thin 
biorecognition layer (Jolly et al., 2015),(Formisano et al., 2015) enabled the detection of 
PSA in physiological buffer solutions. The electronic signal confinement at the IDE 
sensor spots for both rGO thin films and IDEs demonstrate a precedential biosensing 
capability beyond the typical Debye-screening limit in aqueous solutions.  
2. Materials and Methods 
2.1. Chemicals and Reagents 
Amine-terminated, PSA-specific DNA aptamer (5’-NH2-(CH2)6 –TTTT TAAT TAAA 
GCTC GCCA TCAA ATAG CTTT-3’) and (3-Aminopropyl) triethoxysilane (APTES) were 
purchased from Sigma Aldrich, Germany. PSA was obtained from Merck Chemicals Ltd. 
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(Beeston, UK). For the electronic assays, phosphate buffer solution (PB) with pH 7.4 
and 10 mM concentration was prepared from monohydrate phosphate and dinatrium 
hydrogen phosphate salts. Other chemicals for biofunctionalization and biosensing 
experiments as mentioned in the following were purchased from Sigma Aldrich and 
used without further purification. 
2.2. Preparation of GO flakes 
GO flakes were chemically exfoliated by the improved Hummers’ method with additional 
purification and cleaning of GO in further steps. 4g graphite powder (Alfa Aeser, natural, 
-325 mesh, 99.8%) as base material was fully oxidized and exfoliated in a reflux 
condenser with a mixture of H2SO4 and H3PO4 for 24 hours. To restrict the destructive 
power to the carbon lattice but not heavily slow down the exfoliation speed, the reaction 
temperature was stabilized by a cooling water flow system at a mild temperature of 
20° C. Subsequent to the reaction, the mixture was quenched with 400 ml ice water 
mixed with 4 ml H2O2. The obtained GO solution was filtered through a stainless steel 
sieve (200 µm, Spoerl OHG) lined with a polyester fiber. It was essential to eliminate all 
ionic products Mn2+, SO4
2-, PO4
3- and K+ out of the dispersion, which was realized with a 
dialysis membrane (25.4 mm, Th. Geyer GmbH & Co.KG). Dialysis was repeated two 
times to avoid ion inclusions after drying the dispersed GO. Afterwards, the dialyzed GO 
dispersion was mixed with DI water and three times centrifuged at 4500 rpm for 45 min 
until the last supernatant reached at pH value of 2.0. Furthermore, the GO mass was 
mixed with 200 ml HCl and then centrifuged at 4500 rpm for 45 min, following by the 
same step two times in C2H5OH (98 %). Each centrifuge step was followed by GO 
solution filtering in the polyester fiber sieve. The obtained residue was coagulated with 
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150 ml diethyl ether and filtered through the sieve lined with a PTFE filter with mesh 
size of 0.45 µm. The filtered graphene oxide was evacuated for 48 h in the desiccator to 
dry it. The lateral sizes of the resulting flakes ranged from 300 nm to 20 µm due to 
aggregation of the material in the sieve. To obtain lateral mono- and multi-layer GO 
flakes, the dispersion was centrifuged again for two times at 1000 rpm until a final pH 
value of 2.9. GO was water soluble and could be applied in the next steps as spin-
coating solution to form ultra-thin GO films. 
2.3. Fabrication of GO thin films and devices 
In present study, the GO thin films were prepared on 4-inch wafers in a routine clean room 
process. Glass or SiO2/Si wafers were thoroughly cleaned with freshly prepared Caro’s 
acid (H2O2 (30 w %), azeotropic H2SO4 (98 w %) ratio 1:3, T = 120 °C, t = 20 min). 
Afterwards, the wafers were activated by O2 plasma (t = 5 min, 230 W) and 
functionalized by APTES in a gas-phase silanization process. The Au coated surfaces 
were preferably positioned at an angle of about 85 °C with respect to the outlet valve of 
the desiccator to provide a maximum contact area between the substrate and the silane-
saturated gas stream. Then, the pressure inside of the desiccator was gradually 
reduced to 130 mbar such that a continuous gas flow of the silane over the substrate 
was ensured. The reaction time was 2 h. In this process, the surface -OH groups 
replace the O-CH2-CH3 ethoxy-group by a SN2 reaction forming the corresponding 3-
Aminopropylsiloxane APS on the wafer surface (Schmitt, 2014)(Schmitt et al., 2015). 
After the silane coating, the wafer was washed with ethanol. The -NH2 groups on the 
other end of the APS layer, which are accessible on the surfaces can covalently bind 
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GO flakes by reacting with their -COOH groups. 5 mL GO solution pH = 2.9 prepared 
was applied and spin-coated onto the wafer surface. The process details can be found 
in a previous publication (Lu et al., 2018). 
2.4. Thermal reduction of GO devices 
The prepared GO devices were placed inside a vacuum oven (VT5042 EKP, Heraeus, 
Germany) at 350 °C for 10 h to remove the oxygen functional groups and to reduce the 
material gradually. Afterwards, to generate ohmic contacts between the thin films and 
the Au electrodes underneath, the devices were rapidly annealed in a high temperature 
oven (DS-3900-PC-150, INOTHERM, Germany) at 600 °C for 20 s in ambient air. GO 
flakes inside a film are then reduced to rGO and the network of flakes forms a quilted 
layer with bipolar electronic transport properties similar to pristine graphene but with 
much smaller carrier mobilities. 
2.5. rGO thin-film based in-line EIS device 
In the present study, rGO-IDEs devices were used. They were fabricated in the clean 
room at Zweibrücken campus of the University of Applied Sciences Kaiserslautern, 
Germany. IDEs were primarily prepared on 4−inch glass wafers by standard 
photolithography (MA/BA 6, Süss, Germany), metal evaporation (BAK500, Oerlikon 
Balzers, Liechtenstein) and lift-off processes. The electrode material was a bilayer stack: 
top layer was 270 nm Au and bottom layer was 30 nm Ti, which acted as an adhesion 
layer. Overall, we fabricated 72 chips in parallel on the 4-inch wafers. Each chip was 7x7 
mm2 in size and consisted of a 4x4 array with in total 16 individual drains sharing a 
common source-electrode. The resistance and capacitance of each drain electrode was 
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designed to be equal for accurate comparison of measurement results between the 16 
channels. The width and length of a single drain electrode was 5 µm and 100 µm, 
respectively, while the separation distance of the neighboring electrodes was 5 µm. In 
the case of 10 electrode fingers, the effective channel length and width of IDEs were 5 
µm and 1000 µm, respectively. The GO thin film was formed on top of already prepared 
IDEs using spin-coating. This procedure forms ultra-thin but uniform GO films in the 
range of 1.5 – 2 nm per spin coating step. In total six spin-coating steps were applied for 
the devices used here in order to ensure complete films without defects. For patterning 
of the GO thin films, we applied standard photolithography. Afterwards, the films were 
protected by photoresist and the unprotected rest was completely etched away by O2 
reactive ion etching (SI 591 M, SENTECH, Germany).  
2.6. Biofunctionalization of rGO thin-film based in-line EIS biosensor  
In present study, the detailed biosensor preparation procedure with aptamers as receptor 
biomolecules for the PSA dose-response experiments in 10 mM PB solution was as 
following: 80mM N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) 
mixed with 20mM N-Hydroxysuccinimide (NHS) in milliQ water (resistivity 18.2 MΩ·cm) was 
prepared to activate the -COOH groups on the surface of the rGO thin films for a covalent 
immobilization of the amino-terminated aptamers. 100µL of EDC/NHS solution was applied 
on the rGO thin films for 30 mins at room temperature. The amino-terminated aptamers 
were treated as following to gain an optimal position to capture the PSA molecules: The 
microcentrifuge tube, which contained 10 µL of 100 µM amino-terminated aptamers was 
taken out of the freezer and laid in the room temperature for approximate10 mins to 
defreeze it. Fast spinning was applied for 5 seconds to collect the residual droplets on the 
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tube’s sidewall. Then the microcentrifuge tube was immersed at half of is height into a flask 
containing 90 °C hot milliQ water. After the temperature was cooled down to room 
temperature, the microcentrifuge tube was taken out and centrifuged for 5 seconds. The 
100 µM amino-terminated aptamers were diluted to 2 µM by 10 mM PB with a final pH = 
7.4. 100 µL of 2 µM aptamer solution was applied on the rGO thin films for 30 mins at room 
temperature immediately after their EDC/NHS activation. The chips were incubated in 2 µM 
aptamer solution overnight at 4°C. Afterwards, the chips were cleaned for 10 times by 
flowing PB. A blocking solution of 1 mM ethanolamine (pH = 8.5) was prepared by diluting 
with PB and applied on the rGO thin films for 30 mins. This blocking procedure saturated 
the remaining -COOH groups of rGO and suppressed non-specific binding of target 
biomolecules to the surfaces. The different concentrations of PSA for the calibration curve 
were prepared by diluting 100 µM stock solution in 10 mM PB solution. The dose-response 
measurements started by incubating the chips in 100 µL PSA with a concentration of 33 fM 
for 30 mins. After each step, the chips were cleaned for 10 times by 10 mM PB and 
recorded in the in-line EIS configuration by an impedance analyzer (Ivium 
COMPACTSTAT.e, Ivium Techologies, Netherland). The same process was repeated by 
stepwise adding higher PSA concentrations onto the rGO biosensor surfaces as following: 
330 fM, 3.3 pM, 33 pM, 330 pM, 3.3 nM, 33 nM and 330 nM. 
2.7. Control experiments with Human Serum Albumin (HSA)  
To check the specificity of the rGO biosensors, the sensor surface was prepared 
similarly to the protocol described under paragraph 2.6 but without the aptamer 
immobilization. A highly concentrated stock solution of 100 µM human serum albumin 
(HAS) was prepared in 10 mM PB (pH~7.4) and subsequently filtered by a filter with 
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pore size of 0.2 µm. The test solution of 1 µM HSA was prepared by diluting the 100 µM 
stock solution in 10 mM PB (pH~7.4). In the control experiments, this non-specific 
solution was applied similarly to the PSA solutions.  
2.8. Fluidics setup  
A fluidics setup was printed by a 3D printer (Objet350 Connex, Stratays Ltd., Israel). It 
contained two top and bottom parts. The top part had a container in its center and a 
sealing rubber ring at the side. The IDE rGO sensor chips were clamped between these 
two parts, while the rGO arrays were exposed to the liquid. Details of this measurement 
cell were described earlier (Lanche et al., 2014). All of the surface functionalization and 
sensor measurements were carried out within this fluidic cell. 
2.9. Measurement setup  
In the present study, an in-line EIS configuration for the IDE rGO devices was used. The 
EIS measurements were carried out with the two arms of the IDEs acting as working 
electrode (WE) and counter electrode (CE), while an electrochemical Ag/AgCl electrode 
(DRIREF-2SH, WPI, Germany) served as reference electrode (RE). This configuration is 
denoted as in-line EIS in the following. The electronic performance of the IDE rGO sensors 
were compared in 10 mM PB buffer solution under the following conditions: the DC offset 
potential and AC signals were applied to the WE against a constant potential at the RE, the 
standard potential of which is 0.21 mV in 3 M KCl at room temperature. Before the 
electronic measurements, an equilibration time of 30 s was allowed after applying the DC 
bias voltage. The DC potential offset was 50 mV while the AC stimulation voltage was 10 
mV in amplitudes. The frequency range was scanned from 100 kHz to 0.1 Hz. The 
alternating current output Iout (t) flowing from the WE to the CE was then measured by the 
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impedance spectrometer. The 10 mM PB test solution was prepared by dissolving PB 
tablets in highly pure milliQ water (resistivity 18.2 MΩ·cm) with a final pH value of 7.4.  
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3. Results 
We established an aptasensor platform with rGO thin films as transducer layers on top 
of interdigitated electrodes to detect PSA. The biosensor devices were measured with a 
configuration of in-line EIS in 10 mM PB buffer solution (ionic strength 162 mM), which 
determines a Debye screening length of charges in the solution of 0.76 nm. By 
performing the dose-response biosensing experiments, we found that the rGO based 
aptasensor exhibit precedential biosensing capability beyond the Debye-screening limit, 
as well as a wide sensing range covering the clinically relevant concentration range of 
PSA.  
3.1. rGO-IDEs device 
Our devices consist of ultra-thin rGO films, which are composed of small GO flakes and 
are structured on top of 16-channel IDEs arrays on glass wafers. Graphene oxide flakes 
were chemically exfoliated by an improved Hummers’ method (compared materials and 
methods section) and spin-coated on top of APTES-functionalized wafer surfaces with 
pre-fabricated IDEs arrays. The spin-coating procedure is forming uniform thin films, 
which were subsequently patterned into microstructures by standard photolithography 
and O2 plasma etching processes. A scanning electron microscopy (SEM) image of an 
exemplary rGO IDEs electrode structure is shown in Fig. 1A. The thickness of the GO 
patterns were measured by atomic force microscopy (AFM) and were 8 nm thickness, 
as shown in Fig. 1B. 
3.2. Electronic performance of the rGO based in-line EIS 
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In the present study, the in-line EIS measurements were carried out with a three 
electrodes potentiostat setup, as schematically shown in Fig. 2A. The two arms of the 
IDE structures and the Ag/AgCl electrode served as working (WE), counter (CE) and 
reference (RE) electrodes, respectively. A sinusoidal voltage Vin (t) input was applied to 
the WE, which changes its potential relative to the fixed potential of the RE. The 
alternating current Iout (t) output which flowed from WE to CE was recorded. The 
quotient of Vin (t) / Iout (t) is marked as impedance Z of the IDE sensor. In our 
measurements, the input Vin (t) was of 10 mV amplitude in a frequency range from 1Hz 
to 100kHz and a DC bias voltage of 50 mV. In 10 mM PB solution, a typical Bode plot of 
the rGO in-line EIS in shown in Fig. 2B. In the quilted rGO thin film the overlapping 
regions of neighboring rGO flakes bridge the path and meanwhile constrain the direction of 
carriers’ transportation inside the thin film. An electronically equivalent circuit of the rGO thin 
film can be composed as a resistor RrGO, representing the current transport inside the rGO 
flakes, in parallel with a capacitor CrGO, representing the capacitive flake-to-flake transport. 
The current from on side of the IDE to the other side could then pass through the 
electrochemical double layers (EDLs) at the electrode contacts in series with the ohmic 
solution Rsol or in parallel to this through the rGO thin film from WE to CE. The EDL is not 
an ideal capacitor, which can be represented by a CPE for both WE and CE. By 
considering the resistance and capacitance of the rGO thin films into pre-developed circuits 
for bare IDE biosensors (Berdat et al., 2008), an equivalent circuit for our rGO in-line EIS 
can be extracted as indicated in Fig. 2C.  
3.3. PSA biosensing by rGO based in-line EIS  
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In this study, the aptamer sequence used for PSA detection (Jolly et al., 2015)(Formisano 
et al., 2015) was TTT TTA ATT AAA GCT CGC CAT CAA ATA GCT TT from 5' to 3'. The 
5’ end was modified by a 6-carbon chain as a spacer and terminated with an amino group 
for covalent tethering to the sensor surface. 10 mM ethanolamine was used as blocking 
agent to saturate the free-standing -COOH groups on the biosensor surface. The 
schematic of the biosensor surface preparation flow is shown in Fig. 3A. Typically, the 10 
mM PB solution has an ionic strength of 162 mM, which results in a Debye length 0.76 
nm. The aptamer size is approximately 3-5 nm for a fully stretched molecule. Upon folding 
into the 3D aptamer structure this size should be smaller. The target molecule PSA is of 33 
kDa size and its typical diameter is approximately 4.5 nm. Based on the Debye screening 
effect, the depictive schematic with folded aptamers as receptor biomolecules to detect 
PSA on rGO thin film is shown in Fig. 3B 
To reveal the biosensing capability of the rGO IDE aptasensor for detecting PSA 
impedance signals for the dose-response experiments were addressed in the full 
frequency range from 1Hz to 100 kHz, as shown in the Bode plot in Fig. 4A. A close-up 
of the impedance amplitude at the low frequency range 1 Hz to 5 Hz is given in Fig. 4B. 
The biosensing capability to cover the PSA clinically relevant concentration range is 
demonstrated by recording a calibration curve of impedance amplitudes at a small 
frequency       , as shown in Fig. 4C. Five channels are summarized and small 
error bars indicate a very reproducible sensor response. A control experiment with a 
high concentration of HAS showed no response (compare individual data point in Fig 
4C), demonstrating a highly specific detection of PSA. 
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4. Discussion 
Globally, the prostate cancer is one of the leading cause of the cancer-related death in 
men (Baade et al., 2009). As a most common representative biomarker, PSA is used to 
address the presence of prostate cancer and identify the relapse after receiving the 
cancer treatment (Antenor et al., 2005). To detect PSA, plenty of efforts are dedicated 
to exploit the biosensing capability of various nano-/micro- devices to achieve a perfect 
biosensor: highly selective, robust, reliable, cost-effective, disposable, environmentally 
friendly, portable towards point of care usage, with an optimized response to cover the 
clinically relevant concentration range of PSA. However, the currently available label-
free miniaturized biosensors for quantitative detection of PSA severely encounter the 
Debye-screening limitation in physiological matrices.  
In this study, we developed an aptasensor with rGO thin films as transducer layers in an 
in-line EIS device configuration and we tested this biosensor platform to detect PSA in 
similar ionic strength as physiological matrices. The PSA dose-repose experiments 
demonstrated a biosensing capability beyond the Debye screening limitation. This result 
was additionally corroborated by the dose-response experiments of I-V dual sweep, 
which provides an additional proof to reveal the predominated sensing mechanism 
(supporting information S3).  
All rGO-IDE devices used in this study were prepared on a 4-inch wafer from the same 
fabrication bench. The detailed chemical exfoliation procedure to generate GO aqueous 
solution, various characterizations of the GO material, the preparation flow for GO thin-
films, and rGO thin film and device fabrication were detailed in our previous publication 
(Lu et al., 2018). In the present work, the GO aqueous solution was spin-coated on 
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IDEs structure 8 times to form GO thin-films which are complete without pinholes and 
which are topographically uniform. After thermal reduction in vacuum oven at 350°C for 
10 hours and subsequent fast annealing in a high temperature oven at 600 °C for 20 
seconds in the ambient, the GO thin-films was transformed into rGO thin-film. The rGO 
thin-films were patterned by standard photolithography and O2 reactive ion etching for 
SEM and AFM characterizations (Fig. 1a-1b), which indicates that the thickness of rGO 
thin films was 8 nm.  
In order to take advantage of the biosensing capability of the rGO thin films in their 
lateral direction, in-line EIS measurements were carried out (Fig. 2a). The impedance 
signals were collected along the rGO thin film to address the bio-recognition process. 
Already at small frequencies of 1 Hz the responses were stable and showed a reliable 
biosensor readout. Mathematically, the impedance Z is expressed either in its polar 
form          or the Euler’s form          which are noted as Bode plot and 
Nyquist plot, respectively. In our study, the Bode plot was used to analyze the 
biosensing performance of the rGO IDEs. The equivalent circuit as shown in Fig.2c can 
be used to simulate the experimentally obtained Bode plots. The reason to build up 
such an equivalent circuit are as following: For the current flow inside the quilted layer, 
the rGO thin film can be treated as a resistor RrGO in parallel to a capacitor CrGO. The 
capacitance behavior of the rGO thin film was also proven by C-V measurements in dry 
status (supporting information S1). In these measurements, the rGO thin film clearly formed 
Ohmic contacts with the IDEs, but were acting as capacitors under AC stimulation. For the 
current flow through the buffer solution on top of the IDEs, the equivalent electrical circuit of 
two EDLs composed of a resistor and a constant phase element (CPE, is symbolized by Q, 
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          ) are both in series with the solution resistance RSol. To model this, we used a 
CPE instead of an ideal capacitor. This choice was proven by carrying out measurements 
with the same rGO IDEs devices in the configuration of in-line, and classical out-of-line EIS 
(supporting information S2). The out-of-line EIS measurements were carried out in 10 mM 
PB solution as well, where both arms of IDEs structures were acting as one working 
electrode (WE), an additional Pt wire and the Ag/AgCl electrode served as counter 
electrode (CE) and reference electrode (RE), respectively (supporting information, Fig. 
S2). For these measurements, we used an input Vin (t) of 10 mV amplitude as well within 
a frequency range from 1Hz to 100kHz and a DC bias voltage of 50 mV, similar to the 
in-line experiments. From the measurements, we can extract the equivalent circuit 
elements of the EDLs at the interface of the rGO thin films and the buffer solution. As 
demonstrated by the out-of-line EIS experiments, the EDL built on rGO surface is not an 
ideal capacitor, because the slope in the Nyquist plots is not 45° (supporting material, Fig. 
S2c). In this case, a constant phase element (CPE) was used instead. Based on this 
equivalent circuit model, the values of the electronic elements of the circuit can be 
extracted from the simulation:            ,             ,           ,       
          ,          
  ,       .               
  ,          
  ,       .  
To evaluate the biosensing capability, rGO IDEs devices were tested in in-line EIS 
configuration to detect PSA. The biosensors were prepared with anti-PSA aptamers as 
receptor biomolecules using standard EDC/NHS linking chemistry and ethanolamine as 
blocking agent to suppress unspecific binding (Fig. 3a). An aptamer usually consists of a 
short single-stranded DNA sequence. It is of small size and high stability, providing a high 
affinity towards their targets very similar to antibodies with a very sensitive binding of small, 
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organic compounds, large proteins and even whole cells. The structure of the anti-PSA 
aptamer used in our study is folded with a hairpin loop, because two regions of the stand 
are complementary and form local Watson-Crick base pairs (Fig. 3B). The aptamer sizes in 
this configuration are approximately 3-5 nm. The molecular weight of PSA is 33 kDa and its 
diameter is approximately 4.5 nm. The PSA detection was done in 10 mM PB solution with 
an ionic strength 162 mM and corresponding Debye length of 0.76 nm. The Debye length 
depends on the solvent permittivity        , number concentrations of the solute ions     
(/m3) and valence of the solute ions    by following the equation:  
    
     
      
    
, in 
which the vacuum permittivity            
         , relative permittivity of water 
     , Boltzmann constant           
         , room temperature       , the 
charge of an electron               C, the ion number    = molar concentration   NA, 
Avogadro constant           
        .  This measurement condition is very similar to 
the case in physiological solution, which typically has an ionic strength of approximately 
150 mM and its corresponding Debye length is 0.8 nm. The descriptive schematic of the 
EDL with biomolecules in our study are given in Fig. 3b. In this condition, a typical field-
effect based semiconductor biosensor will hardly show any sensing due to the Debye-
screening of charges. The bound PSA targets locate outside the EDL, so their charges 
should not be able to modulate the surface potential of the transducer layer.  
However, in our experiments the rGO IDE based in-line EIS biosensors exhibited a very 
good sensing performance beyond this Debye-screening limit. The Bode plots (Fig.4a) 
obtained from PSA dose-response experiments show sensing capability at a low frequency 
range of 1-10 Hz and in the impedance phase around 1 kHz. The bonded PSA leads to 
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increases of impedance amplitudes at these frequencies (Fig.4b). The biosensor without 
aptamer receptor molecules were measured in 10 mM PB solution for 3 times exchange of 
the test solution and 1 times exchange of the cable. The baseline of the experiments was 
calculated from these four measurements. HSA was used as highly concentrated, non-
specific control experiment. After 1 µM HSA incubation, three channels were measured 
two times to obtain the non-specific control signal. The specific signals corresponding to the 
PSA binding can be clearly distinguished from the non-specific signal (red color) of 1 µM 
HSA. The limit of detection was about 33 pM. In Fig. 4c the clinically relevant concentration 
range is marked (4-10ng/ml corresponding to 115-290pM). It can be seen that our 
sensor platform perfectly matches this range with highest signal resolution there.  
To reveal the sensing mechanism of the bio-recognition capability beyond the Debye-
screening limitation at low frequencie,s the dose-response of rGO-IDEs aptasensor to 
detect PSA were also measured by dual I-V sweeps. The obtained results (supporting 
information S3) show that the PSA binding also leads to an increase of the rGO thin film 
resistance. This coincides with the results from the PSA dose-response experiments 
with the in-line EIS configuration. It is obvious from these findings that the rGO thin films 
can respond to binding of PSA biomolecules. Eventually this binding leads to a 
disturbance of the EDL on top of the rGO material. This would affect the rGO layer in 
terms of its ‘gate dielectrics’, which is this EDL rather than the direct detection of the 
biomolecule charges. The tendency of the observed resistance increases can be 
explained by the bipolar transport properties of the rGO thin films (Fig. S3b-3c). PSA is 
negatively charged. Therefore, the surface potential change on the rGO thin film is in 
total negative. In an ideal case, the carrier type affected by this should be the bipolar left 
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arm of the characteristics (holes as dominant carrier). Because the Dirac point was 
shifted to the left as well, the responding carriers are at the bipolar right arm (electrons 
as dominant carriers). The more PSA molecules bind, the larger amount of negative 
gate voltage is applied to the rGO thin film. Therefore, the conductivity of the rGO 
channel decreases and its resistance increases. This could explain the results obtained 
in our in-line EIS and the dual I-V sweep experiments for PSA detection. 
5. Conclusions 
The ultra-thin rGO films structured on top of micro sized IDE sensors were utilized as 
transducer layer for an in-line, electrochemical impedance spectroscopy aptasensor 
platform to detect PSA. The dose-response measurements were carried out in 10 mM 
buffer solution, which has an ionic strength of 162 mM and hence a Debye length onlky 
0.76 nm. This test solution is very close to typical physiological solutions such as blood 
serum. The biosensor signals were extracted from impedance amplitudes in Bode plots 
at low frequencies (1-10 Hz). The sensing range of the PSA biosensors covered a wide 
range from 33 pM to 330 nM showing increasing impedance amplitudes. We 
demonstrated that our rGO thin films preserve a bipolar transport property similar to 
graphene with the clear advantage to be integrated into a standard process flow as 
spin-coating layer. The binding of PSA biomolecules increased the rGO channel 
impedance amplitudes at low frequency levels i.e. resistances. This tendency was 
confirmed by DC I-V sweeps which showed similar changes. The established biosensor 
platform can detect PSA fully covering its clinically relevant range (4-10 ng/ml) in 
physiological buffer concentrations. We are fully convinced that our work lightens up the 
application direction to use rGO thin-films as nanometer thick transducer layers in 
biosensor platforms to directly detect various biomarkers in physiological matrices.  
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Supporting Information 
The supporting information file contains characterizations of rGO thin films in dry 
conditions and in a classical EIS configuration. In addition the PSA detection results 
recorded in DC I-V sweeps are presented there. 
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Figures 
Fig. 1. Characterizations of rGO thin-films: (A) Scanning electron microscopy image of 
an rGO thin-film patterned on top of interdigitated gold microelectrodes (IDEs). (B) 
Atomic force microscopic image of a GO thin-film at the edge of a structured pattern. 
Step size shows a thickness of 8 nm with a smooth GO surface.  
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Fig. 2. Electronic characterization of the rGO thin-film based in-line EIS: (A) Schematics 
of an rGO thin-film in EIS configuration, where the two arms of the IDE structures and 
an electrochemical Ag/AgCl electrode serve as working electrode (WE), counter 
electrode (CE) and reference electrode (RE), respectively. (B) Experimental and 
simulated Bode plots of in-line impedimetric spectroscopy with rGO thin films as 
transducer layers in 10 mM PB solution. (C) Equivalent circuits of rGO thin-film based 
in-line impedimetric spectroscopy in aqueous solution. Rint1(2) and Qint1(2) are the 
resistance and capacitance of the electrical double layers that build up on the interface 
of the electrodes and the liquid. Rsol is the resistance of the electrolyte solution. RrGO and 
CrGO are the resistance and the capacitance of the rGO thin film, respectively. Value of 
the equivalent circuit elements are listed in the table. 
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Fig. 3. Descriptive schematics of an rGO IDE EIS experiment to detect PSA: (A) 
Preparation flow of aptasensors: The -COOH groups on the surface of rGO thin film 
were activated by EDC/NHS chemistry, so that the amino-terminated receptor 
biomolecules can be immobilized. Afterwards, the surface was saturated by 
ethanolamine to suppress non-specific binding. In the following, PSA was detected. (B) 
Descriptive schematics of an rGO IDE biosensor with aptamer receptor biomolecules, 
which locates within the Debye length (0.76 nm) on the rGO transducer layer.  
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Fig. 4. Dose-response experiment to extract a calibration curve for PSA detection: (A) 
Bode plot of the PSA dose-response experiments. (B) The close-up shows the 
impedance amplitudes at low frequencies (1-5 Hz). (C) Amplitude calibration curve of 
the PSA dose-response experiments by rGO-based, in-line EIS with aptamers as 
receptor molecules in physiological buffer solution. 1 µM human serum antigens (HSA) 
was used as a non-specific control (red data point). 
 
  
31 
 
Highlights: 
 
1. We developed a process to fabricate highly reproducible biosensors based on 
interdigitated electrode (IDE) structures. These structures we bridged with 
reduced graphene oxide (rGO) thin films. 
2. Reduced graphene oxide thin films exhibit a bipolar carrier transport 
characteristics similar to pristine graphene. We read out the rGO based IDEs in 
an in-line electrochemical impedance spectroscopy configuration. 
3. Sensors were functionalized with short aptamers, which are highly specific to 
prostate specific antigens (PSA). At low frequency (1-10 Hz) sensors showed 
robust response towards different concentrations of PSA. A control experiment 
did not show a response demonstrating the highly specific PSA detection. 
4. Detection was possible in a physiological buffer concentration with a Debye-
length similar to human serum. Therefore, this sensor scheme can overcome the 
typical Debye-screening limitation of charges in liquid environments. 
5. The limit of detection and the high resolution of the readout is fully covering the 
clinically relevant concentration range for biomedical application of this assay. 
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